Sandia to Use Arrayit’s Nanotech Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Arrayit said today that Sandia National Laboratories will use the company’s nanotechnology platform to develop microarrays for use in anti-bioterror efforts.

Sandia Labs will use Arrayit’s nanoliter technology to develop microarrays, biosensors, and other sensor tools for use in detecting biological and chemical agents that could be part of a terrorism event.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.